home / stock / ntra / ntra news

NTRA News and Press, Natera Inc. From 02/19/19

Stock Information
Company Name: Natera Inc.
Stock Symbol: NTRA
Market: NASDAQ
Website: natera.com
Menu
NTRA NTRA Quote NTRA Short NTRA News NTRA Articles NTRA Message Board
Get NTRA Alerts

News, Short Squeeze, Breakout and More Instantly...
NTRA - Natera Presents Outcomes Data at SMFM Annual Meeting Showing Strong Clinical Performance of Its SNP-Based Non-Invasive Prenatal Test

SAN CARLOS, Calif. , Feb. 19, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, presented data at the Society for Maternal-Fetal Medicine (SMFM) Annual Pregnancy Meeting showing strong clinical performance of its Panorama ® SNP-b...
NTRA - Natera Announces Agreement with One Lambda to Co-Distribute Its Kidney Transplant Rejection Test

SAN CARLOS, Calif. , Feb. 1, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of cell-free DNA, today announced a partnership with Thermo Fisher Scientific's One Lambda brand, a global leader in human le...

NTRA - Consolidated Research: 2019 Summary Expectations for Marathon Petroleum, AMC Entertainment, JetBlue Airways, Acceleron Pharma, Natera, and AquaVenture - Fundamental Analysis, Key Performance Indications

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Marathon Petroleum Corporation (NYSE:MPC), AMC Entertainment Holdings, In...

NTRA - Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection

SAN CARLOS, Calif. , Jan. 7, 2019 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced clinical validation study results published in the Journal of Clinical Medicine , 1 demonstrating the highly accurate performance of its donor-derived cell-...
NTRA - Notable earnings after Thursday's close

AGO , AL , ALTR , AMBR , AMC , AMPH , AQN , ARRS , ASRT , ATVI , BOJA , BPI , BRS , BW , CBPX , COLD , COLL , CTL , CYRX , DBX , DIS , DOX , ECOM , EGAN , EPAY , ERI , FGEN , FOE , FSCT , FSM , FTCH , GMED , HDP , HTZ , ICUI , JAG , JJSF , LGF.A , LOPE...

NTRA - Natera Announces Third Quarter 2018 Earnings Conference Call

SAN CARLOS, Calif. , Nov. 1, 2018 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its third quarter ended Sept. 30, 2018 , after the market close o...

NTRA - Natera Signs Agreement with Bristol-Myers Squibb to Investigate Signatera(TM) ctDNA Assay as a Potential Biomarker for Opdivo (nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial

SAN CARLOS, Calif. , Sept. 13, 2018 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced an agreement with Bristol-Myers Squibb to use Natera's Signatera™ custom circulating tumor DNA (ctDNA) assay in a Phase 2 study in the a...
NTRA - Small Caps Are Rising, Biotechs Can't Be Far Behind

Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...

Previous 10 Next 10